Hikma shares climb on new outlook, targets $5 billion sales by 2030
Hikma Pharmaceuticals PLC on Thursday unveiled new medium-term guidance forecasting high single-digit revenue and operating profit growth in the three years to 2027.
The London-based pharmaceutical...
Thu, 15/05/2025 - 12:52